LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Titel:
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Auteur:
Urva, Shweta Coskun, Tamer Loh, Mei Teng Du, Yu Thomas, Melissa K Gurbuz, Sirel Haupt, Axel Benson, Charles T Hernandez-Illas, Martha D’Alessio, David A Milicevic, Zvonko